Medexus Pharmaceuticals Inc (MDP : TSX)
Common Stock
$4.93
CAD
-0.11 (-2.18%)
Last updated: 2026-10-30
Follow MDP
MDP
Medexus Pharmaceuticals Inc
WealthAwesomePerformance
1 Day
-2.18%
1 Week
+0.00%
1 Month
-1.40%
YTD
+59.55%
Key Statistics
Market Cap
$154.93M
52W High
$5.50
52W Low
$2.51
P/E Ratio
-
50 Day MA
$5.01
200 Day MA
$4.15
Beta
1.73
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/30/2026 | $5.00 | $5.00 | $4.90 | $4.93 | $4.93 | 32,571 |
| 10/29/2026 | $4.84 | $5.07 | $4.80 | $5.04 | $5.04 | 56,410 |
| 10/28/2026 | $4.93 | $4.95 | $4.89 | $4.95 | $4.95 | 24,633 |
| 10/27/2026 | $4.87 | $4.97 | $4.83 | $4.97 | $4.97 | 31,502 |
| 10/26/2026 | $4.93 | $4.93 | $4.83 | $4.87 | $4.87 | 10,092 |
| 10/23/2026 | $4.86 | $4.94 | $4.84 | $4.93 | $4.93 | 24,700 |
| 10/22/2026 | $4.95 | $5.02 | $4.83 | $4.94 | $4.94 | 40,490 |
| 10/21/2026 | $4.94 | $4.99 | $4.88 | $4.98 | $4.98 | 16,524 |
| 10/20/2026 | $4.87 | $4.92 | $4.87 | $4.92 | $4.92 | 14,470 |
| 10/19/2026 | $4.89 | $4.91 | $4.83 | $4.85 | $4.85 | 11,136 |
Analyst Price Targets
Based on analyst covering MDP · as of Sep 17, 2026
Wall Street analysts forecast MDP stock price to rise 47.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.25
+47.1% Upside
Current Price
C$4.93
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDP's historical volatility
30-Day Vol
28.2%
Annualized
90-Day Vol
37.7%
Annualized
Trend (90d)
-3.4%
Annualized drift
90d Mean
C$4.87
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$4.91 | C$4.46 – C$5.41 |
| 60 trading days | C$4.89 | C$4.26 – C$5.61 |
| 90 trading days | C$4.87 | C$4.12 – C$5.76 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Medexus Pharmaceuticals Inc
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis, psoriasis, and juvenile idiopathic arthritis; Rupall, a prescription allergy medication; and GRAFAPEX, an injection to treat allogeneic hematopoietic stem cell transplantation in adult and pediatric patients, acute myeloid leukemia (AML), and myelodysplastic syndrome. The company's products portfolio also includes Cuvposa, a glycopyrrolate oral solution; Naproxen, a Pediapharm naproxen suspension; Otixal, a ciprofloxacin and flucinolone acetonide; and intraarticular, a triamcinolone hexacetonide injectable suspension. In addition, it offers over the counter products comprising Nyda, a topical treatment indicated for the eradication of head lice; Relaxa, an osmotic laxative to treat occasional constipation in adults; Oralvisc to reduce joint pain and enhance joint function in osteoarthritis of the knee; and Calcia Calcium and vitamin D products. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. was founded in 2000 and is based in Toronto, Canada.
Financials
- Revenue (TTM)
- $103.30M
- EBITDA
- $16.64M
- Profit Margin
- -2.29%
- ROE (TTM)
- -4.68%
- EPS (Diluted)
- -0.10
- Book Value
- 2.14
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About MDP
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| TVA-B | TVA Group Inc | $2.65 | +31.19% |
| EGLX | Enthusiast Gaming Holdings Inc | $0.03 | +20.00% |
| MX | Methanex Corporation | $99.85 | +13.76% |
| PRN | Profound Medical Corp | $9.18 | +11.81% |
| YRB | Yorbeau Resources Inc | $0.05 | +11.11% |
| EDT | Spectral Med Inc | $1.03 | +10.75% |
| NVO | Novo Resources Corp | $0.06 | +9.09% |
| BDI | Black Diamond Group Limited | $21.11 | +7.38% |
MDP.TO news timeline
15 articles covering MDP.TO, most recent first
LatestWhat's Going On With Medexus Pharmaceuticals Inc Stock Tuesday?
September 2026
August 2026
- What's Going On With Medexus Pharmaceuticals Inc Stock Sunday?
- What's Going On With Medexus Pharmaceuticals Inc Stock Sunday?
- Why Medexus Pharmaceuticals Inc stock is sliding today
- What's Going On With Medexus Pharmaceuticals Inc Stock Sunday?
- Why Medexus Pharmaceuticals Inc stock is skyrocketing today
- Why Medexus Pharmaceuticals Inc stock is skyrocketing today
- Medexus Pharmaceuticals Inc MDP Earnings Miss Estimates by 74.6%
- Will Medexus Pharmaceuticals Inc (MDP) Beat Estimates Again in Its Next Earnings Report?
- What's Going On With Medexus Pharmaceuticals Inc Stock Sunday?